Growth Factor Independence 1 Antagonizes a p53-Induced DNA Damage Response Pathway in Lymphoblastic Leukemia

详细信息    查看全文

• 作者：Cyrus Khandanpour¹ ; ³ ; ⁹ ; James D. Phelan⁴ ; ⁹ ; ¹⁰ ; Lothar Vassen¹ ; Judith Schü ; tte⁶ ; Riyan Chen¹ ; Shane R. Horman⁴ ; ¹¹ ; Marie-Claude Gaudreau¹ ; ² ; Joseph Krongold¹ ; ⁷ ; Jinfang Zhu⁸ ; William E. Paul⁸ ; Ulrich Dü ; hrsen³ ; Bertie Gö ; ttgens⁶ ; H. Leighton Grimes⁴ ; ⁵ ; ^{lee.grimes@cchmc.org} ; Tarik Mö ; rö ; y¹ ; ² ; ⁷ ; ^{tarik.moroy@ircm.qc.ca}
• 刊名：Cancer Cell
• 出版年：2013
• 出版时间：11 February, 2013
• 年：2013
• 卷：23
• 期：2
• 页码：200-214
• 全文大小：2688 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferencesrsion=""1.0"" encoding=""UTF-8""?>

Summary

Most patients with acute lymphoblastic leukemia (ALL) fail current treatments highlighting the need for better therapies. Because oncogenic signaling activates a p53-dependent DNA damage response and apoptosis, leukemic cells must devise appropriate countermeasures. We show here that growth factor independence 1 (Gfi1) can serve such a function because Gfi1 ablation exacerbates p53 responses and lowers the threshold for p53-induced cell death. Specifically, Gfi1 restricts p53 activity and expression of proapoptotic p53 targets such as Bax, Noxa (Pmaip1), and Puma (Bbc3). Subsequently, Gfi1 ablation cures mice from leukemia and limits the expansion of primary human T-ALL xenografts in mice. This suggests that targeting Gfi1 could improve the prognosis of patients with T-ALL or other lymphoid leukemias.